Midgard Science

Labs / CDMO: development & manufacturing

Ailux

Shanghai, China · ailuxbio.com

Ailux develops AI-enabled biologic therapies for immune-mediated diseases. It operates across early R&D in the United States, translational medicine in the United Kingdom, and clinical development in China.

They take quote requests by email.

What they offer

  • AI-native biologics discovery and development

    Uses AI, proprietary data, and wet-lab validation to move biologic candidates from target identification through optimization and translational science.

  • AI platform licensing

    Licenses its proprietary AI platform technology, including XtalFold®, to external partners.

  • Comprehensive wet-lab evaluation

    Tests AI-generated designs through high-throughput, large-scale specialized assays in-house.

  • Biologics therapeutic design

    Develops de novo and multiparametric optimized biologic candidates with complex multispecific architectures.

What they work on

Modalities
Antibody, Bispecific
Assays and studies
high-throughput specialized assays, wet-lab validation
Scale and capacity
30,000+ sq. ft. wet lab, 3 strategic hubs, 180 employees
Therapeutic areas
immune-mediated diseases, respiratory, immunology
Sites
Somerville, United States · Shanghai, China
Team
180 employees
Serves
United States, United Kingdom, China, global
Address
100 Chestnut Street Suite 300 Somerville, MA 02143

Similar labs. Alphalyse, Asimov, Aurigene Pharmaceutical Services, Avid Bioservices

Found in a contract services directory. Listing built from ailuxbio.com. Work here? Claim this listing.

Ailux · Midgard Science